<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02666443</url>
  </required_header>
  <id_info>
    <org_study_id>REB13-1350</org_study_id>
    <nct_id>NCT02666443</nct_id>
  </id_info>
  <brief_title>Low Dose Dexamethasone in Supraclavicular Blocks</brief_title>
  <official_title>Low Dose Dexamethasone as an Adjuvant to Supraclavicular Brachial Plexus Blocks: A Prospective Randomized, Double Blinded, Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brachial plexus nerve blocks provide superior analgesia over opioids while avoiding unwanted
      side effects. Single shot blocks with local anesthetic alone usually do not last the duration
      of the acute post-surgical pain period. This has led to the exploration of multiple adjuvants
      to increase the duration of single shot blocks, the most promising adjuvant being
      dexamethasone.

      Peri-neural administration is an off-label use of dexamethasone. While no adverse events have
      been reported in human clinical studies, logic would dictate that we minimize the dose needed
      to produce the desired effect. Most studies thus far have used peri-neural dexamethasone
      doses ranging from 4-10 mg. However, Albrecht et al. found no difference in block duration
      comparing 4 mg and 8 mg doses while Liu et al. reported equivalent block duration using doses
      of 1, 2 and 4 mg.

      Recent studies have evaluated whether systemic and peri-neural administrations of
      dexamethasone are equivalent, which would in turn imply a site of action. Results have been
      mixed. Four studies concluded peri-neural and intravenous administration are equivalent at
      prolonging analgesia, though one study had methodological errors, including the
      administration of intravenous dexamethasone to all patients. All of these studies used
      dexamethasone doses of 8 to 10 mg. One study where a lower dose (4 mg) was used found that
      peri-neural administration prolonged block duration whereas intravenous did not.

      With that, the rationale of our study is to determine if equivalent block-prolonging
      analgesia can be achieved using low dose (1 mg) dexamethasone given peri-neural or
      intravenous. Clinical experience at our centre has been that 1 mg dexamethasone added to 20
      mL produces similar block duration to that reported in published studies using higher doses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will evaluate the block-prolonging efficacy of dexamethasone 1 mg in
      supraclavicular blocks. The investigators will be answering essentially two questions. First,
      how long do supraclavicular blocks last when low dose dexamethasone is used as an adjunct.
      Only one study has looked at doses this low (Liu et al. 2015). Some methodological problems
      with this study include evaluation of shoulder surgery using supraclavicular blocks, which
      may or may not cover the posterior port site; use of the endpoint of &quot;time to first
      analgesic&quot;, which may or may not indicate actual block duration; and low numbers powered to
      80%, which may yield spurious results. To avoid these issues the investigators chose upper
      limb surgery, a type of block which will definitely cover the entire surgical site, and an
      endpoint of time to first pain at surgical site, regardless of whether analgesic is needed.
      The investigators are also powering to 95% and recruiting higher numbers of patients.

      The second question evaluates the efficacy of 1 mg of intravenous dexamethasone. The study is
      powered to address this question, but in doing so is also powered adequately to address the
      first question. Studies to date have mixed results and methodological errors. No other
      studies have evaluated this dose of intravenous dexamethasone.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first sensation of pain at the surgical site.</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of motor blockade</measure>
    <time_frame>72 hours</time_frame>
    <description>time (in hours) to return of full pre-operative strength in the operative limb</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morphine or morphine equivalent usage in the first 48 h postoperatively</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of nausea and vomiting and pruritus in the first 48 h</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>numerical rating scale (NRS) pain scores at 8 h, 24 h, 48 h, and post-operative day 7</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>residual paraesthesias or motor blockade at 7 days.</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">306</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Osteoarthritis</condition>
  <condition>Nerve Entrapment</condition>
  <condition>Ligament Injury</condition>
  <arm_group>
    <arm_group_label>Control (C)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control intervention (no dexamethasone)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peri-neural (N)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Peri-neural Dexamethasone 1 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous Dexamethasone 1 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control intervention (no dexamethasone)</intervention_name>
    <description>Patients receive a supraclavicular brachial plexus block with 30 mL of solution containing 0.5% bupivacaine, 1:400,000 epinephrine, 0.1 mL normal saline, and an intravenous solution of 50 mL normal saline.</description>
    <arm_group_label>Control (C)</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Peri-neural Dexamethasone 1 mg</intervention_name>
    <description>Patients receive a supraclavicular brachial plexus block with 30 mL of solution containing 0.5% bupivacaine, 1:400,000 epinephrine, 0.1 mL dexamethasone 1% (1 mg dexamethasone), and an intravenous solution of 50 mL normal saline.</description>
    <arm_group_label>Peri-neural (N)</arm_group_label>
    <other_name>Peri-neural</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous Dexamethasone 1 mg</intervention_name>
    <description>Patients receive a supraclavicular brachial plexus block with 30 mL of solution containing 0.5% bupivacaine, 1:400,000 epinephrine, 0.1 mL normal saline, and an intravenous solution of 49.9 mL normal saline with 0.1mL dexamethasone 1%</description>
    <arm_group_label>Intravenous</arm_group_label>
    <other_name>IV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult 18 - 80 years

          -  BMI equal to or less than 35

          -  Upper limb surgery

          -  Normal pre-operative sensation in the operative limb

        Exclusion Criteria:

          -  Pre-operative opioid greater than 4 Tylenol #3 per day (or equivalent)

          -  Pre-existing, fluctuating neurologic injury involving operative upper limb

          -  Patient refusal or patient inability to provide consent

          -  Suspected inability to comply with study procedures, including language difficulties
             or medical history and/or concomitant disease (skin infection at site of needle
             insertion) as judged by the investigator or attending anesthesiologist, reason for
             exclusion will be recorded.

          -  Patient pregnancy

          -  Patient BMI &gt; 35

          -  Patient allergy to any of the drugs used in the protocol

          -  Surgical concern of postoperative neurological injury from surgical manipulation.

          -  Brittle diabetics

          -  Other contraindication to receiving a block (coagulopathy, significant respiratory
             risk, etc.)

          -  Surgeon refusal (e.g. concerns about compartment syndrome); reason for exclusion will
             be recorded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathan JD Brown, BMSc, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathan JD Brown, BMSc, MD</last_name>
    <phone>403-956-3883</phone>
    <email>nathan.brown@albertahealthservices.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melissa T Jack, MD, PhD</last_name>
    <phone>403-956-3883</phone>
    <email>melissa.jack@albertahealthservices.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>South Health Campus</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3M 1M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan JD Brown, BMSc MD</last_name>
      <phone>403-956-3883</phone>
      <email>nathan.brown@albertahealthservices.ca</email>
    </contact>
    <contact_backup>
      <last_name>Melissa T Jack, MD PhD FRCPC</last_name>
      <phone>403-956-3883</phone>
      <email>melissa.jack@albertahealthservices.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Shaylyn H Montgomery, MSc MD FRCPC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark A Kostash, MD FRCPC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Fredrickson MJ, Krishnan S, Chen CY. Postoperative analgesia for shoulder surgery: a critical appraisal and review of current techniques. Anaesthesia. 2010 Jun;65(6):608-24. doi: 10.1111/j.1365-2044.2009.06231.x. Review.</citation>
    <PMID>20565394</PMID>
  </reference>
  <reference>
    <citation>Noss CD, MacKenzie LD, Kostash MA. Adjuvant dexamethasone: innovation, farce, or folly? Reg Anesth Pain Med. 2014 Nov-Dec;39(6):540-5. doi: 10.1097/AAP.0000000000000148.</citation>
    <PMID>25275574</PMID>
  </reference>
  <reference>
    <citation>Choi S, Rodseth R, McCartney CJ. Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2014 Mar;112(3):427-39. doi: 10.1093/bja/aet417. Epub 2014 Jan 10. Review.</citation>
    <PMID>24413428</PMID>
  </reference>
  <reference>
    <citation>Huynh TM, Marret E, Bonnet F. Combination of dexamethasone and local anaesthetic solution in peripheral nerve blocks: A meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2015 Nov;32(11):751-8. doi: 10.1097/EJA.0000000000000248. Review.</citation>
    <PMID>25774458</PMID>
  </reference>
  <reference>
    <citation>Albrecht E, Kern C, Kirkham KR. A systematic review and meta-analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia. 2015 Jan;70(1):71-83. doi: 10.1111/anae.12823. Epub 2014 Aug 14. Review.</citation>
    <PMID>25123271</PMID>
  </reference>
  <reference>
    <citation>Knight JB, Schott NJ, Kentor ML, Williams BA. Neurotoxicity of common peripheral nerve block adjuvants. Curr Opin Anaesthesiol. 2015 Oct;28(5):598-604. doi: 10.1097/ACO.0000000000000222. Review.</citation>
    <PMID>26207854</PMID>
  </reference>
  <reference>
    <citation>Williams BA, Hough KA, Tsui BY, Ibinson JW, Gold MS, Gebhart GF. Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine. Reg Anesth Pain Med. 2011 May-Jun;36(3):225-30. doi: 10.1097/AAP.0b013e3182176f70.</citation>
    <PMID>21519308</PMID>
  </reference>
  <reference>
    <citation>Williams BA, Butt MT, Zeller JR, Coffee S, Pippi MA. Multimodal perineural analgesia with combined bupivacaine-clonidine-buprenorphine-dexamethasone: safe in vivo and chemically compatible in solution. Pain Med. 2015 Jan;16(1):186-98. doi: 10.1111/pme.12592. Epub 2014 Oct 23.</citation>
    <PMID>25339320</PMID>
  </reference>
  <reference>
    <citation>Castillo J, Curley J, Hotz J, Uezono M, Tigner J, Chasin M, Wilder R, Langer R, Berde C. Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology. 1996 Nov;85(5):1157-66.</citation>
    <PMID>8916834</PMID>
  </reference>
  <reference>
    <citation>De Oliveira GS Jr, Almeida MD, Benzon HT, McCarthy RJ. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2011 Sep;115(3):575-88. doi: 10.1097/ALN.0b013e31822a24c2. Review.</citation>
    <PMID>21799397</PMID>
  </reference>
  <reference>
    <citation>Waldron NH, Jones CA, Gan TJ, Allen TK, Habib AS. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth. 2013 Feb;110(2):191-200. doi: 10.1093/bja/aes431. Epub 2012 Dec 5. Review.</citation>
    <PMID>23220857</PMID>
  </reference>
  <reference>
    <citation>Desmet M, Braems H, Reynvoet M, Plasschaert S, Van Cauwelaert J, Pottel H, Carlier S, Missant C, Van de Velde M. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study. Br J Anaesth. 2013 Sep;111(3):445-52. doi: 10.1093/bja/aet109. Epub 2013 Apr 15.</citation>
    <PMID>23587875</PMID>
  </reference>
  <reference>
    <citation>Rahangdale R, Kendall MC, McCarthy RJ, Tureanu L, Doty R Jr, Weingart A, De Oliveira GS Jr. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double-blind, placebo-controlled study. Anesth Analg. 2014 May;118(5):1113-9. doi: 10.1213/ANE.0000000000000137.</citation>
    <PMID>24686045</PMID>
  </reference>
  <reference>
    <citation>Fredrickson Fanzca MJ, Danesh-Clough TK, White R. Adjuvant dexamethasone for bupivacaine sciatic and ankle blocks: results from 2 randomized placebo-controlled trials. Reg Anesth Pain Med. 2013 Jul-Aug;38(4):300-7. doi: 10.1097/AAP.0b013e318292c121.</citation>
    <PMID>23698496</PMID>
  </reference>
  <reference>
    <citation>Abdallah FW, Johnson J, Chan V, Murgatroyd H, Ghafari M, Ami N, Jin R, Brull R. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block: a randomized, triple-arm, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2015 Mar-Apr;40(2):125-32. doi: 10.1097/AAP.0000000000000210. Erratum in: Reg Anesth Pain Med. 2015 Jul-Aug;40(4):398.</citation>
    <PMID>25629321</PMID>
  </reference>
  <reference>
    <citation>Kawanishi R, Yamamoto K, Tobetto Y, Nomura K, Kato M, Go R, Tsutsumi YM, Tanaka K, Takeda Y. Perineural but not systemic low-dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local Reg Anesth. 2014 Apr 5;7:5-9. doi: 10.2147/LRA.S59158. eCollection 2014.</citation>
    <PMID>24817819</PMID>
  </reference>
  <reference>
    <citation>Liu J, Richman KA, Grodofsky SR, Bhatt S, Huffman GR, Kelly JD 4th, Glaser DL, Elkassabany N. Is there a dose response of dexamethasone as adjuvant for supraclavicular brachial plexus nerve block? A prospective randomized double-blinded clinical study. J Clin Anesth. 2015 May;27(3):237-42. doi: 10.1016/j.jclinane.2014.12.004. Epub 2015 Jan 28.</citation>
    <PMID>25637938</PMID>
  </reference>
  <reference>
    <citation>Bolin ED, Wilson S. Perineural Versus Systemic Dexamethasone: Questions Remain Unanswered. Reg Anesth Pain Med. 2015 Jul-Aug;40(4):393-4. doi: 10.1097/AAP.0000000000000262.</citation>
    <PMID>26079360</PMID>
  </reference>
  <reference>
    <citation>Beecroft CL, Coventry DM. Anaesthesia for shoulder surgery. Continuing Education in Anaesthesia, Critical Care &amp; Pain 2008 ; 8: 193-98</citation>
  </reference>
  <reference>
    <citation>Perlas A, Lobo G, Lo N, Brull R, Chan VW, Karkhanis R. Ultrasound-guided supraclavicular block: outcome of 510 consecutive cases. Reg Anesth Pain Med. 2009 Mar-Apr;34(2):171-6. doi: 10.1097/AAP.0b013e31819a3f81.</citation>
    <PMID>19282715</PMID>
  </reference>
  <reference>
    <citation>Ultrasound for Regional Anesthesia, Supraclavicular Block. 2008; http://www.usra.ca/supneedle.php accessed September 22, 2015</citation>
  </reference>
  <reference>
    <citation>Cummings KC 3rd, Napierkowski DE, Parra-Sanchez I, Kurz A, Dalton JE, Brems JJ, Sessler DI. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. Br J Anaesth. 2011 Sep;107(3):446-53. doi: 10.1093/bja/aer159. Epub 2011 Jun 14.</citation>
    <PMID>21676892</PMID>
  </reference>
  <reference>
    <citation>Shrestha BR, Maharjan SK, Shrestha S, Gautam B, Thapa C, Thapa PB, Joshi MR. Comparative study between tramadol and dexamethasone as an admixture to bupivacaine in supraclavicular brachial plexus block. JNMA J Nepal Med Assoc. 2007 Oct-Dec;46(168):158-64.</citation>
    <PMID>18340366</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2016</study_first_submitted>
  <study_first_submitted_qc>January 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>September 2, 2016</last_update_submitted>
  <last_update_submitted_qc>September 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Dr. Nathan Brown</investigator_full_name>
    <investigator_title>Staff Anesthesiologist, Calgary Department of Anesthesia</investigator_title>
  </responsible_party>
  <keyword>brachial plexus</keyword>
  <keyword>supraclavicular</keyword>
  <keyword>duration</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Nerve Compression Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>I am not sure what the entirety of a &quot;yes&quot; answer entails, or with whom the data would be shared. Hence, undecided.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

